ORIGINAL RESEARCH
Published on 01 Dec 2022
MM/PB(GB)SA benchmarks on soluble proteins and membrane proteins
doi 10.3389/fphar.2022.1018351
- 4,914 views
- 18 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Computational Methods in Anti-cancer Drug Design and Development
Computational Methods in Anti-cancer Drug Design and Development
8,026
Total downloads
26k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 11 Oct 2022
A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitors
doi 10.3389/fphar.2022.971369
- 3,842 views
- 18 citations
MINI REVIEW
Published on 07 Sep 2022
Osthole: An up-to-date review of its anticancer potential and mechanisms of action
doi 10.3389/fphar.2022.945627
- 3,373 views
- 20 citations
ORIGINAL RESEARCH
Published on 30 Aug 2022
Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy
doi 10.3389/fonc.2022.953321
- 1,461 views
- 3 citations
ORIGINAL RESEARCH
Published on 10 Aug 2022
Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C
doi 10.3389/fonc.2022.915512
- 2,255 views
- 11 citations
ORIGINAL RESEARCH
Published on 23 Jun 2022
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
doi 10.3389/fphar.2022.934729
- 2,953 views
- 8 citations
ORIGINAL RESEARCH
Published on 23 May 2022
Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies
doi 10.3389/fphar.2022.854965
- 2,078 views
- 12 citations
HYPOTHESIS AND THEORY
Published on 19 May 2022
A Theoretical Study on the Medicinal Properties and Eletronic Structures of Platinum(IV) Anticancer Agents With Cl Substituents
doi 10.3389/fonc.2022.860159
- 1,124 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore